Belite Bio Income Statement (2020-2025) | BLTE

Income Statement Dec2020 Dec2021 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating items
Research & Development (Quarter) 1.58B1.19B0.01B5.72B5.52B0.01B0.00B6.76B9.08B6.84B7.25B9.40B11.05B10.31B14.62B
Selling, General & Administrative (Quarter) 0.93B1.35B0.00B1.16B1.35B0.00B0.00B1.56B1.39B2.90B4.20B6.12B6.55B12.71B13.45B
Operating Expenses (Quarter) 2.51B2.54B0.01B6.88B6.87B0.01B0.01B8.33B10.47B9.74B11.46B15.52B17.60B23.02B28.08B
Operating Income (Quarter) -2.51B-2.54B-0.01B-0.00B-6.87B-0.01B-6955.00B-8.33B-10.47B-9.74B-0.00B-15.52B-17.60B-23.02B-28.08B
EBIT (Quarter) -2.51B-2.54B-0.01B-0.00B-6.87B-0.01B-6955.00B-8.33B-10.47B-9.74B-0.00B-15.52B-17.60B-23.02B-28.08B
Non-operating items
Other Non Operating Income (Quarter) 0.00B-0.00B
Non Operating Income (Quarter) 0.12B0.14B-0.00B-0.01B0.06B0.00B-0.00B0.46B0.98B1.06B1.36B1.24B1.28B1.33B2.75B
Net income details
EBT (Quarter) -2.39B-2.40B-0.01B-6.89B-6.81B-0.01B-0.01B-7.87B-9.49B-8.68B-10.10B-14.28B-16.32B-21.69B-25.32B
Tax Provisions (Quarter) 0.01B0.00B0.00B-0.00B0.01B-0.01B
Profit After Tax (Quarter) -2.39B-2.40B-0.01B-6.89B-6.81B-0.01B-0.01B-7.87B-9.49B-8.68B-10.10B-14.28B-16.32B-21.69B-25.32B
Income from Continuing Operations (Quarter) -2.39B-2.40B-0.01B-6.89B-6.81B-0.01B-0.01B-7.87B-9.49B-8.67B-10.10B-14.28B-16.32B-21.69B-25.32B
Consolidated Net Income (Quarter) -2.39B-2.40B-0.01B-6.89B-6.81B-0.01B-0.01B-7.87B-9.49B-8.67B-10.10B-14.28B-16.32B-21.69B-25.32B
Income towards Parent Company (Quarter) -2.39B-2.40B-0.01B-6.89B-6.81B-0.01B-0.01B-7.87B-9.49B-8.67B-10.10B-14.28B-16.32B-21.69B-25.32B
Net Income towards Common Stockholders (Quarter) -2.39B-2.40B-0.01B-6.89B-6.81B-0.01B-0.01B-7.87B-9.49B-8.67B-10.10B-14.28B-16.32B-21.69B-25.32B
Additional items
EPS (Basic) (Quarter) -0.120.100.270.33-0.26-0.400.25-0.270.310.280.320.45-0.500.650.70
EPS (Weighted Average and Diluted) (Quarter) -0.12-0.10-0.27-0.33-0.26-0.40-0.250.270.310.280.320.450.500.65-0.70
Shares Outstanding (Weighted Average) (Quarter) 0.01B0.01B0.00B400.00B400.00B400.00B0.03B29.80B30.65B30.93B0.03B32.60B32.63B34.90B0.03B
Shares Outstanding (Diluted Average) (Quarter) 0.01B0.01B0.02B0.03B0.03B0.03B
EBITDA (Quarter) -2.57B-2.57B-0.01B-6.88B-6.89B-0.01B-0.01B-7.97B-9.50B-8.60B-10.36B-14.26B-16.19B-21.61B-25.43B
Tax Rate (Quarter) -0.09%-0.04%-0.01%0.01%-0.08%0.07%